Breast Cancer Clinical Trials

Showing 5321-5340 of 5,597 trials

Reflexology: An Intervention for Advanced Breast Cancer

NCT01577420

The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for women undergoing chemotherapy for late stage (III or IV) breast cancer within the context of conventional medical care. Quality of life will be assessed via intermediate indicators: 1) physical indicators (greater physical functioning, lower presence of symptoms) 2) emotional indicators (greater spirituality, lower anxiety, and lower depressive symptomology); and the outcome indicator of quality of life.

Breast Cancer

Michigan State University451 participantsStarted Aug 2005

Evanston, Illinois, United States • Evanston, Illinois, United States • Flint, Michigan, United States +9 more locations

UNKNOWNPhase 1

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

NCT00982631

A study to examine the combination of temsirolimus and Caelyx® (chemotherapeutic) in advanced or recurrent breast, endometrial and ovarian cancer.

Advanced/Recurrent Breast CancerEndometrial CancerOvarian Cancer

Radboud University Medical Center30 participantsStarted Jun 2009

Nijmegen, Gelderland, Netherlands

Reflexology: An Intervention for Advanced Breast Cancer

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Related Searches

Arthralgia During Anastrozole Therapy for Breast Cancer

Effect of a Natural Health Product on Urinary Estrogen Metabolites

CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer

Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging

Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

Pyrazoloacridine in Treating Women With Metastatic Breast Cancer

Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

3-Dimensional Form and Soft Tissue Biomechanics of the Breast

Arimidex Therapy Compliance Electronic Monitoring System

Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast Cancer

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function